Prognostic Stratification Of Patients With T3N1M0 Non ... - PubMed
Có thể bạn quan tâm
The .gov means it’s official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation- Clipboard
- My Bibliography
- Collections
- Citation manager
Save citation to file
Format: Summary (text) PubMed PMID Abstract (text) CSV Create file CancelEmail citation
Email address has not been verified. Go to My NCBI account settings to confirm your email and then refresh this page. To: Subject: Body: Format: Summary Summary (text) Abstract Abstract (text) MeSH and other data Send email CancelAdd to Collections
- Create a new collection
- Add to an existing collection
Add to My Bibliography
- My Bibliography
Your saved search
Name of saved search: Search terms: Test search terms Would you like email updates of new search results? Saved Search Alert Radio Buttons- Yes
- No
Create a file for external citation management software
Create file CancelYour RSS Feed
Name of RSS Feed: Number of items displayed: 5 10 15 20 50 100 Create RSS Cancel RSS Link CopyFull text links
Springer Full text links Actions
CiteCollectionsAdd to Collections- Create a new collection
- Add to an existing collection
Page navigation
- Title & authors
- Abstract
- References
- MeSH terms
- LinkOut - more resources
Abstract
In the 1997 revision of the TNM staging system for lung cancer, patients with T3N0M0 disease were moved from stage IIIA to stage IIB since these patients have a better prognosis. Despite this modification, the local lymph node metastasis remained the most important prognostic factor in patients with lung cancer. The present study aimed to evaluate the prognosis of patients with T3N1 disease as compared with that of patients with stages IIIA and IIB disease. During 7-year period, 313 patients with non-small cell lung cancer (297 men, 16 women) who had resection were enrolled. The patients were staged according the 2007 revision of Lung Cancer Staging by American Joint Committee on Cancer. The Kaplan-Meier statistics was used for survival analysis, and comparisons were made using Cox proportional hazard method. The 5-year survival of patients with stage IIIA disease excluding T3N1 patients was 40%, whereas the survival of the patients with stage IIB disease was 66% at 5 years. The 5-year survival rates of stage III T3N1 patients (single-station N1) was found to be higher than those of patients with stage IIIA disease (excluding pT3N1 patients, P = 0.04), while those were found to be similar with those of patients with stage IIB disease (P = 0.4). Survival of the present cohort of patients with T3N1M0 disease represented the survival of IIB disease rather than IIIA non-small cell lung cancer. Further studies are needed to suggest further revisions in the recent staging system regarding T3N1MO disease.
PubMed Disclaimer
References
-
- Eur J Cardiothorac Surg. 2001 May;19(5):555-61 - PubMed
-
- Chest. 1997 Jun;111(6):1710-7 - PubMed
-
- Chest. 1997 Jul;112(1):229-34 - PubMed
-
- J Thorac Cardiovasc Surg. 1995 Sep;110(3):601-5 - PubMed
-
- Chest. 2000 Feb;117(2):374-9 - PubMed
MeSH terms
- Adenocarcinoma / mortality Actions
- Search in PubMed
- Search in MeSH
- Add to Search
- Adenocarcinoma / pathology* Actions
- Search in PubMed
- Search in MeSH
- Add to Search
- Adenocarcinoma / surgery Actions
- Search in PubMed
- Search in MeSH
- Add to Search
- Carcinoma, Large Cell / mortality Actions
- Search in PubMed
- Search in MeSH
- Add to Search
- Carcinoma, Large Cell / pathology* Actions
- Search in PubMed
- Search in MeSH
- Add to Search
- Carcinoma, Large Cell / surgery Actions
- Search in PubMed
- Search in MeSH
- Add to Search
- Carcinoma, Neuroendocrine / mortality Actions
- Search in PubMed
- Search in MeSH
- Add to Search
- Carcinoma, Neuroendocrine / pathology* Actions
- Search in PubMed
- Search in MeSH
- Add to Search
- Carcinoma, Neuroendocrine / surgery Actions
- Search in PubMed
- Search in MeSH
- Add to Search
- Carcinoma, Non-Small-Cell Lung / mortality Actions
- Search in PubMed
- Search in MeSH
- Add to Search
- Carcinoma, Non-Small-Cell Lung / pathology* Actions
- Search in PubMed
- Search in MeSH
- Add to Search
- Carcinoma, Non-Small-Cell Lung / surgery Actions
- Search in PubMed
- Search in MeSH
- Add to Search
- Carcinoma, Squamous Cell / mortality Actions
- Search in PubMed
- Search in MeSH
- Add to Search
- Carcinoma, Squamous Cell / pathology* Actions
- Search in PubMed
- Search in MeSH
- Add to Search
- Carcinoma, Squamous Cell / surgery Actions
- Search in PubMed
- Search in MeSH
- Add to Search
- Female Actions
- Search in PubMed
- Search in MeSH
- Add to Search
- Follow-Up Studies Actions
- Search in PubMed
- Search in MeSH
- Add to Search
- Humans Actions
- Search in PubMed
- Search in MeSH
- Add to Search
- Lung Neoplasms / mortality Actions
- Search in PubMed
- Search in MeSH
- Add to Search
- Lung Neoplasms / pathology* Actions
- Search in PubMed
- Search in MeSH
- Add to Search
- Lung Neoplasms / surgery Actions
- Search in PubMed
- Search in MeSH
- Add to Search
- Male Actions
- Search in PubMed
- Search in MeSH
- Add to Search
- Middle Aged Actions
- Search in PubMed
- Search in MeSH
- Add to Search
- Neoplasm Staging* Actions
- Search in PubMed
- Search in MeSH
- Add to Search
- Pneumonectomy Actions
- Search in PubMed
- Search in MeSH
- Add to Search
- Postoperative Care Actions
- Search in PubMed
- Search in MeSH
- Add to Search
- Preoperative Care Actions
- Search in PubMed
- Search in MeSH
- Add to Search
- Prognosis Actions
- Search in PubMed
- Search in MeSH
- Add to Search
- Retrospective Studies Actions
- Search in PubMed
- Search in MeSH
- Add to Search
- Survival Rate Actions
- Search in PubMed
- Search in MeSH
- Add to Search
LinkOut - more resources
Full Text Sources
- Springer
Medical
- MedlinePlus Health Information
Springer [x] Cite Copy Download .nbib .nbib Format: AMA APA MLA NLM Send To - Clipboard
- Save
- My Bibliography
- Collections
- Citation Manager
NCBI Literature Resources
MeSH PMC Bookshelf Disclaimer
The PubMed wordmark and PubMed logo are registered trademarks of the U.S. Department of Health and Human Services (HHS). Unauthorized use of these marks is strictly prohibited.
Từ khóa » T3n1m0
-
Cancer Staging - NCI
-
Breast Cancer: Stages
-
Nasopharyngeal Cancer: Stages And Grades
-
Staging & Grading | Diagnosis | About Bowel Cancer
-
Non-small Cell Lung Cancer Staging - American Cancer Society
-
Colorectal Cancer Stages - American Cancer Society
-
[PDF] Is Surgery Better Than Chemoradiation For T3N1M0 Non-small Cell ...
-
TNM Staging | Lung Cancer
-
TNM Staging For Breast Cancer
-
Prognostic Stratification Of Patients With T3N1M0 Non-small Cell Lung ...
-
[PDF] S1 Table: Demographics Data Of 39 Patients With Laryngeal Cancer
-
[PDF] SUPPLEMENTARY TABLE 1. Clinical And Biological Characteristics ...
-
Table 1 Patient And Tumour Characteristics - Cancer Imaging